FMS:NYE-Fresenius Medical Care AG (USD)

EQUITY | Medical Care Facilities | New York Stock Exchange

Last Closing

USD 28.78

Change

-0.71 (-2.41)%

Market Cap

USD 23.44B

Volume

0.64M
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Fresenius Medical Care AG & Co. KGaA is a kidney dialysis company, which is operating in both the field of dialysis products and dialysis services.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-28 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

+0.21 (+0.06%)

USD 90.60B
THC Tenet Healthcare Corporation

+1.59 (+0.97%)

USD 15.37B
UHS Universal Health Services Inc

+0.66 (+0.35%)

USD 12.76B
EHC Encompass Health Corp

+0.49 (+0.41%)

USD 12.18B
DVA DaVita HealthCare Partners Inc

-0.33 (-0.24%)

USD 11.16B
CHE Chemed Corp

+0.18 (+0.03%)

USD 8.48B
CON Concentra Group Holdings Paren..

+0.13 (+0.61%)

USD 2.93B
ARDT Ardent Health Partners, Inc.

-0.12 (-0.81%)

USD 2.59B
NHC National HealthCare Corporatio..

+0.76 (+0.73%)

USD 1.68B
BKD Brookdale Senior Living Inc

-0.02 (-0.31%)

USD 1.61B

ETFs Containing FMS

TPYP Tortoise Capital Series T.. 4.00 % 0.40 %

+0.06 (+0.15%)

N/A
PUI Invesco DWA Utilities Mom.. 3.75 % 0.60 %

+0.25 (+0.15%)

USD 0.07B
RYU 3.37 % 0.40 %

N/A

N/A
TPHD Timothy Plan High Dividen.. 1.41 % 0.00 %

+0.19 (+0.15%)

USD 0.29B
ULVM VictoryShares US Value Mo.. 1.37 % 0.20 %

+0.21 (+0.15%)

USD 0.16B
UMI:CA CI U.S. MidCap Dividend I.. 0.90 % 0.41 %

-0.06 (0.15%)

CAD 0.02B
UMI-B:CA CI WisdomTree U.S. MidCap.. 0.90 % 0.00 %

N/A

N/A
DON WisdomTree U.S. MidCap Di.. 0.86 % 0.38 %

+0.23 (+0.15%)

N/A
TPLC Timothy Plan US Large/Mid.. 0.57 % 0.00 %

+0.13 (+0.15%)

USD 0.32B
LKOR FlexShares Credit-Scored .. 0.37 % 0.22 %

+0.32 (+0.15%)

USD 0.04B
SCHM Schwab U.S. Mid-Cap ETF 0.00 % 0.05 %

+0.06 (+0.15%)

N/A
BKMC BNY Mellon US Mid Cap Cor.. 0.00 % 0.00 %

+0.15 (+0.15%)

USD 0.34B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 27.12% 80% B- 95% A
Dividend Return 3.48% 100% F 90% A-
Total Return 30.60% 92% A 96% N/A
Trailing 12 Months  
Capital Gain 38.83% 91% A- 93% A
Dividend Return 3.80% 89% A- 63% D
Total Return 42.63% 95% A 94% A
Trailing 5 Years  
Capital Gain -31.80% 24% F 13% F
Dividend Return 10.16% 75% C 25% F
Total Return -21.64% 24% F 12% F
Average Annual (5 Year Horizon)  
Capital Gain -11.55% 13% F 6% D-
Dividend Return -8.98% 13% F 7% C-
Total Return 2.57% 80% B- 57% F
Risk Return Profile  
Volatility (Standard Deviation) 28.24% 65% D 33% F
Risk Adjusted Return -31.80% 13% F 10% F
Market Capitalization 23.44B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care Facilities) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 20.30 N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector